Julie L. Gerberding's Net Worth

$28.1 Million

Estimate Recalculated Sep 9, 2024 12:33AM EST

Who is Julie L. Gerberding

Julie L. Gerberding has an estimated net worth of $28.1 Million. This is based on reported shares across multiple companies, which include CERNER CORP /MO/, Merck & Co., Inc., AfterNext HealthTech Acquisition Corp., and HilleVax, Inc..

SEC CIK

Julie L. Gerberding's CIK is 0001628884

Past Insider Trading and Trends

2021 was Julie L. Gerberding's most active year for acquiring shares with 7 total transactions. Julie L. Gerberding's most active month to acquire stocks was the month of April. 2016 was Julie L. Gerberding's most active year for disposing of shares, totalling 6 transactions. Julie L. Gerberding's most active month to dispose stocks was the month of October. 2018 saw Julie L. Gerberding paying a total of $2,476,272.88 for 78,657 shares, this is the most they've acquired in one year. In 2020 Julie L. Gerberding cashed out on 239,017 shares for a total of $12,021,841.27, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CERNER CORP /MO/

Investor
Updated Jun 09, 2022
Form 4
-100.00%
-15.03K
$95.00
-$1.43M
Jun 09, 2022
Disposition
Jun 07
Form 4
26.92%
3.19K
May 20, 2021
15.03K
Grant
May 19
Form 4
45.72%
3.72K
May 27, 2020
11.84K
Grant
May 22
Form 4
-49.38%
-7.93K
$71.82
-$569.39K
Aug 23, 2019
8.13K
Sale
Aug 22
Form 4
28.45%
3.56K
Jun 03, 2019
16.06K
Grant
May 30
Form 4
48.81%
4.10K
May 22, 2018
12.50K
Grant
May 18
Form 4
86.67%
3.90K
May 25, 2017
8.40K
Grant
May 24
Form 4
4.50K
Mar 06, 2017
4.50K
Grant
Mar 03
Form 3
Mar 06, 2017
Showing 9 results

Merck & Co., Inc.

EVP, Chief Patient Officer
Updated Feb 28, 2022
Form 4
24.39%
9.55K
$73.51
$702.02K
Feb 28, 2022
48.71K
Grant
Feb 24
Form 4
-57.32%
-96.27K
$87.91
-$8.46M
Nov 03, 2021
71.69K
Sale
Nov 01
Form 4
39.80K
May 06, 2021
78.96K
Grant
May 04
Form 4
47.35%
12.59K
$72.62
$913.92K
Mar 02, 2021
39.16K
Grant
Feb 26
Form 4
-57.72%
-36.28K
$80.00
-$2.90M
Jul 20, 2020
26.58K
Sale
ScheduledJul 17
Form 4
33.23K
May 05, 2020
77.98K
Grant
May 01
Form 4
19.90%
7.37K
$76.56
$564.32K
Mar 03, 2020
44.41K
Grant
Feb 28
Form 4
-73.38%
-102.07K
$89.34
-$9.12M
Jan 15, 2020
37.04K
Sale
ScheduledJan 13
Form 4
28.23K
May 07, 2019
83.84K
Grant
May 03
Form 4
18.79%
8.75K
$80.38
$703.08K
Feb 27, 2019
55.29K
Grant
Feb 25
Form 4
-36.00%
-36.22K
$64.91
-$740.95K
Nov 08, 2018
64.37K
Sale
Nov 07
Form 4
-17.91%
-9.97K
$59.66
-$594.96K
May 16, 2018
45.72K
Sale
May 15
Form 4
29.28K
May 08, 2018
84.97K
Grant
May 04
Form 4
19.61%
9.06K
$54.72
$495.87K
Mar 01, 2018
55.28K
Grant
Feb 27
Form 4
34.24K
May 09, 2017
79.58K
Grant
May 05
Form 4
-2.32%
-1.08K
$62.38
-$260.12K
May 03, 2017
45.34K
Options
May 02
Form 4
9.42%
3.71K
$65.85
$244.11K
Mar 01, 2017
43.06K
Grant
Feb 27
Form 4
-68.62%
-85.52K
$50.78
-$1.58M
Nov 08, 2016
39.12K
Sale
Nov 07
Form 4
54.33K
May 12, 2016
92.98K
Grant
May 10
Form 4
-3.89%
-1.57K
$54.09
-$301.17K
May 09, 2016
38.65K
Options
May 06
Form 4
10.36%
3.38K
$50.77
$171.45K
Feb 24, 2016
35.99K
Grant
Feb 22
Form 4
-47.56%
-38.37K
$48.14
-$709.55K
May 11, 2015
42.30K
Sale
May 08
Form 4
190.55%
48.32K
$59.86
-$301.22K
May 05, 2015
73.68K
Options
May 01 - May 02
Form 4
14.68%
2.74K
$58.30
$159.51K
Feb 25, 2015
21.37K
Grant
Feb 23
Form 3
Jan 07, 2015
18.51K
Showing 25 results

AfterNext HealthTech Acquisition Corp.

Investor
Updated Aug 11, 2021
Form 3
Aug 11, 2021
Showing 1 results

HilleVax, Inc.

Investor
Updated Jun 09, 2023
Form 4
22.50K
Jun 09, 2023
22.50K
Grant
Jun 07
Form 4
25.00K
Aug 23, 2022
25.00K
Grant
Aug 19
Form 3
Apr 28, 2022
42.03K
Showing 3 results